⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Apsen Farmacêutica and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Apsen Farmacêutica
↗São Paulo, Brazil
Apsen Farmacêutica is a prominent Brazilian pharmaceutical company founded in 1969. It focuses on research, development, and manufacturing of medicines across various therapeutic areas, including the central nervous system, urology, orthopedics, and gastroenterology, with a strong commitment to self-care and innovation.
The company operates as a private, 100% national entity and has established itself as a significant player in the Brazilian market. It emphasizes investment in R&D, human capital, and technology to provide high-quality therapeutic options to healthcare professionals and patients.
CLASSIFICATION
Company Type:Pharma
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Diversified Pharmaceuticals
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$50M-$100M
Founded:1969
Ownership:private
Status:operating
FUNDING
Investors:Magnum Capital Industrial Partners
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3
Modalities:Small molecule
Active Trials:2
Trial Phases:Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Bioiberica (collaboration on mobility and wellness products)
COMPETITION
Position:Leader
Competitors:EMS, Eurofarma, Biolab Farmacêutica
LEADERSHIP
Key Executives:
Renato Spallicci - President
Kleber Vargas Nunes - Technical and New Business Vice President
Márcio Castanha - Vice-presidente Comercial
LINKS
Website:apsen.com.br
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Apsen Farmacêutica. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.